| Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trials. | |
| | |
MedLine Citation:
|
PMID: 10700048 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We determined acute outcome in 148 consecutive patients with ST segment elevation myocardial infarction undergoing angioplasty including 72 patients (48.7%) considered ineligible for primary angioplasty trials. Overall, in-hospital mortality for acute infarct angioplasty was 12%, with fivefold higher mortality in the trial-ineligible group (21% vs. 4%, P = 0.003). Thus, primary angioplasty trials continue to exclude nearly 50% of acute infarction patients and reported mortality rates of primary angioplasty trials are likely to be significantly lower than the unselected in-hospital mortality rates. Cathet. Cardiovasc. Intervent. 49:237-243, 2000. |
| | |
Authors:
|
H L Dauerman; D S Pinto; K K Ho; C M Gibson; R E Kuntz; D J Cohen; D S Baim; J P Carrozza |
Related Documents
:
|
8644638 - Effect of delayed percutaneous transluminal coronary angioplasty of occluded coronary a... 9605048 - A comparison of percutaneous transluminal coronary angioplasty in the department of vet... 12201968 - Establishing primary angioplasty as the preferred treatment for acute myocardial infarc... 2146328 - Parametric assessment of myocardial perfusion during interventional cardiac catheteriza... 11002448 - Diagnosis of hypertrophic cardiomyopathy and screening for the phenotype suggestive of ... 8335828 - Radiofrequency current delivery by way of a bipolar tricuspid annulus-mitral annulus el... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions Volume: 49 ISSN: 1522-1946 ISO Abbreviation: Catheter Cardiovasc Interv Publication Date: 2000 Mar |
Date Detail:
|
Created Date: 2000-03-31 Completed Date: 2000-03-31 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 100884139 Medline TA: Catheter Cardiovasc Interv Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 237-43 Citation Subset: IM |
Copyright Information:
|
Copyright 2000 Wiley-Liss, Inc. |
Affiliation:
|
Cardiovascular Division, Beth Israel-Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA. hdauerman@msn.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary
/
mortality* Boston Clinical Trials as Topic Hospital Mortality* Humans Myocardial Infarction / mortality*, therapy* Patient Selection* Retrospective Studies Stents Survival Analysis Treatment Outcome |
| Comments/Corrections | |
Comment In:
|
Catheter Cardiovasc Interv. 2000 Mar;49(3):244-5
[PMID:
10700049
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Role of apoptosis in gastric epithelial turnover.
Next Document: Procedural costs of digital vs. analog archiving of diagnostic cardiac catheterizations.